Want to see CH:MEDX full AI Analyst Report?
Total Valuation
medmix AG has a market cap or net worth of CHF337.11M. The enterprise value is CHF567.67M.
Market CapCHF337.11M
Enterprise ValueCHF567.67M
Share Statistics
medmix AG has 41,262,370 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding41,262,370
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
medmix AG’s return on equity (ROE) is 0.02 and return on invested capital (ROIC) is 2.61%.
Return on Equity (ROE)0.02
Return on Assets (ROA)<0.01
Return on Invested Capital (ROIC)2.61%
Return on Capital Employed (ROCE)0.03
Revenue Per Employee166.92K
Profits Per Employee2.38K
Employee Count2,684
Asset Turnover0.46
Inventory Turnover3.76
Valuation Ratios
The current PE Ratio of medmix AG is 49.6. medmix AG’s PEG ratio is -0.37.
PE Ratio49.6
PS Ratio1.02
PB Ratio1.08
Price to Fair Value1.08
Price to FCF13.76
Price to Operating Cash Flow4.76
PEG Ratio-0.37
Income Statement
In the last 12 months, medmix AG had revenue of 448.00M and earned 6.40M in profits. Earnings per share was 0.16.
Revenue448.00M
Gross Profit161.90M
Operating Income27.40M
Pretax Income9.00M
Net Income6.40M
EBITDA79.70M
Earnings Per Share (EPS)0.16
Cash Flow
In the last 12 months, operating cash flow was 67.80M and capital expenditures -34.50M, giving a free cash flow of 33.30M billion.
Operating Cash Flow67.80M
Free Cash Flow33.30M
Free Cash Flow per Share0.81
Dividends & Yields
medmix AG pays an annual dividend of CHF0.1, resulting in a dividend yield of 4.54%
Dividend Per ShareCHF0.1
Dividend Yield4.54%
Payout Ratio64.10%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.05
52-Week Price Change-34.95%
50-Day Moving Average8.54
200-Day Moving Average9.50
Relative Strength Index (RSI)31.84
Average Volume (3m)115.75K
Important Dates
medmix AG upcoming earnings date is Jul 23, 2026, TBA (Confirmed).
Last Earnings DateFeb 26, 2026
Next Earnings DateJul 23, 2026
Ex-Dividend Date―
Financial Position
medmix AG as a current ratio of 1.54, with Debt / Equity ratio of 77.59%
Current Ratio1.54
Quick Ratio1.10
Debt to Market Cap0.56
Net Debt to EBITDA2.82
Interest Coverage Ratio3.04
Taxes
In the past 12 months, medmix AG has paid 2.00M in taxes.
Income Tax2.00M
Effective Tax Rate0.22
Enterprise Valuation
medmix AG EV to EBITDA ratio is 8.57, with an EV/FCF ratio of 20.51.
EV to Sales1.52
EV to EBITDA8.57
EV to Free Cash Flow20.51
EV to Operating Cash Flow10.08
Balance Sheet
medmix AG has CHF113.90M in cash and marketable securities with CHF330.30M in debt, giving a net cash position of -CHF216.40M billion.
Cash & Marketable SecuritiesCHF113.90M
Total DebtCHF330.30M
Net Cash-CHF216.40M
Net Cash Per Share-CHF5.24
Tangible Book Value Per ShareCHF1.54
Margins
Gross margin is 36.14%, with operating margin of 6.12%, and net profit margin of 1.43%.
Gross Margin36.14%
Operating Margin6.12%
Pretax Margin2.01%
Net Profit Margin1.43%
EBITDA Margin17.79%
EBIT Margin6.12%
Analyst Forecast
The average price target for medmix AG is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast-7.42%
EPS Growth Forecast―